Quest Diagnostics (DGX) Non-Current Assets (2009 - 2026)
Quest Diagnostics (DGX) posted Non-Current Assets of $14.1 billion for Q2 2026, little changed sequentially from $14.1 billion in Q1 2026, and up 2.35% YoY from $13.8 billion in Q2 2025.
Quest Diagnostics (DGX) Non-Current Assets (2009 - 2026) Analysis & Trends
Quest Diagnostics has reported Non-Current Assets for 18 years, with the latest figure at $14.1 billion in Q2 2026.
- Quarterly Non-Current Assets rose 2.35% year-over-year to $14.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $55.8 billion (up 2.03% YoY) and the FY2025 annual result came in at $13.8 billion, up 0.62% from the prior year.
- Non-Current Assets steadied at $14.1 billion in Q2 2026 per DGX's latest filing, from $14.1 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $14.1 billion in Q1 2026 and troughed at $10.9 billion in Q2 2022.
- A 5-year average of $12.4 billion and a median of $11.8 billion in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets gained 0.12% in 2023, then gained 18.12% in 2024.
- Over 5 years, Non-Current Assets stood at $10.9 billion in 2022, then rose by 6.5% to $11.6 billion in 2023, then climbed by 18.12% to $13.8 billion in 2024, then increased by 0.62% to $13.8 billion in 2025, then increased by 1.79% to $14.1 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $14.1 billion, $14.1 billion, and $13.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn | 1.93 Bn |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn | 8.30 Bn |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn | 23.66 Bn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | 962.59 Mn |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn | 3.82 Bn |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn | 2.32 Bn |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn | 14.10 Bn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 14.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.10 Bn |
| Mar 31, 2026 | 14.11 Bn |
| Dec 31, 2025 | 13.85 Bn |
| Sep 30, 2025 | 13.79 Bn |
| Jun 30, 2025 | 13.77 Bn |
| Mar 31, 2025 | 13.72 Bn |
| Dec 31, 2024 | 13.76 Bn |
| Sep 30, 2024 | 13.47 Bn |
| Jun 30, 2024 | 11.86 Bn |
| Mar 31, 2024 | 11.73 Bn |
| Dec 31, 2023 | 11.65 Bn |
| Sep 30, 2023 | 11.67 Bn |
| Jun 30, 2023 | 11.69 Bn |
| Mar 31, 2023 | 10.98 Bn |
| Dec 31, 2022 | 10.94 Bn |
| Sep 30, 2022 | 10.89 Bn |
| Jun 30, 2022 | 10.89 Bn |
| Mar 31, 2022 | 10.97 Bn |
| Dec 31, 2021 | 10.87 Bn |
| Sep 30, 2021 | 10.72 Bn |